Cardium Therapeutics (CXM) Reports In-Line Q1 Loss of 2c/Share
Tweet Send to a FriendGet Alerts CXM Hot Sheet
Price: $0.10 +11.11%
Financial Fact:
Total operating expenses: 2.51M
Today's EPS Names:
NED, OESX, WSTL, More
Financial Fact:
Total operating expenses: 2.51M
Today's EPS Names:
NED, OESX, WSTL, More
Trade CXM Now!
Cardium Therapeutics, Inc. (NYSE: CXM) reported Q1 EPS of ($0.02), versus ($0.02) reported last year.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- Lowes Cos. (LOW) Misses Q1 EPS by 2c; Reaffirms FY13 Outlook
- LTX-Credence Corp (LTXC) Misses Q3 EPS by 2c; Issues Weak Q4 Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
